A paradox: the 5-HT₂-receptor antagonist ketanserin restores the 5-HT-induced contraction depressed by methysergide in large coronary arteries of calf: allosteric regulation of 5-HT₂-receptorsKAUMANN, A. J; FRENKEN, M.Naunyn-Schmiedeberg's archives of pharmacology. 1985, Vol 328, Num 3, pp 295-300, issn 0028-1298Article

Receptor specificity of the 5HT₂ receptor antagonist, LY 53857COHEN, M. L; COLBERT, W; WITTENAUER, L. A et al.Drug development research. 1985, Vol 5, Num 4, pp 313-321, issn 0272-4391Article

N₁-methyl-2-[¹²⁵I]LSD([¹²⁵I]MIL), a preferred ligand for serotonin 5-HT₂ receptorsHOFFMAN, B. J; KARPA, M. D; LEVER, J. R et al.European journal of pharmacology. 1985, Vol 110, Num 1, pp 147-148, issn 0014-2999Article

Ketanserin alters [³H]Pserotonin uptake and release in rat hypothalamusOFFORD, S. J; WARWICK, R. O. JR.European journal of pharmacology. 1984, Vol 104, Num 3-4, pp 379-382, issn 0014-2999Article

Is waning of a 5-hydroxytryptamine (5-HT)-mediated syndrome due to 5-HT₂ receptor down-regulation?KOSHIKAWA, N; SMOKCUM, R. W. J; STEPHENSON, J. D et al.Neuroscience letters. 1985, Vol 55, Num 3, pp 279-282, issn 0304-3940Article

Amitriptyline and femoxetine, but not clomipramine or citalopram, antagonize hyperthermia induced by directly acting 5-hydroxytryptamine-like drugs in heat adapted ratsPAWŁOWSKI, L.Journal of pharmacy and pharmacology. 1984, Vol 36, Num 3, pp 197-199, issn 0022-3573Article

7-Amino-8-[¹²⁵I]-ketanserin ([¹²⁵I]AMIK), a highly sensitive, serotonin-S₂ receptor ligandWOUTERS, W; VAN DUN, J; LADURON, P. M et al.Biochemical pharmacology. 1986, Vol 35, Num 19, pp 3199-3202, issn 0006-2952Article

Platelet α₂-adrenergic receptors in depressionKAFKA, M. S; PAUL, S. M.Archives of general psychiatry. 1986, Vol 43, Num 1, pp 91-95, issn 0003-990XArticle

Human platelet 5-HT₂ receptor binding sites re-evaluated : a criticism of recurrent techniquesSTECKLER, T; RÜGGEBERG-SCHMIDT, K; MÜLLER-OERLINGHAUSEN, B et al.Journal of neural transmission. 1993, Vol 92, Num 1, pp 11-24, issn 0300-9564Article

IN VIVO BINDING OF (³H) KETANSERIN ON SEROTONIN S₂-RECEPTORS IN RAT BRAINLADURON PM; JANSSEN PFM; LEYSEN JE et al.1982; EUR. J. PHARMACOL.; ISSN 0014-2999; NLD; DA. 1982; VOL. 81; NO 1; PP. 43-48; BIBL. 13 REF.Article

Vascular serotonin receptors: correlation with 5-HT₁ and 5-HT₂ binding sitesPEROUTKA, S. J.Biochemical pharmacology. 1984, Vol 33, Num 15, pp 2349-2353, issn 0006-2952Article

5HT₂-receptors and serotonin release : their role in human platelet aggregationCERRITO, F; LAZZARO, M. P; GAUDIO, E et al.Life sciences (1973). 1993, Vol 53, Num 3, pp 209-215, issn 0024-3205Article

Species differences in the pharmacology of the 5-hydroxytryptamine₂ receptor : strucutally specific differentiation by ergolines and tryptaminesNELSON, D. L; LUCAITES, V. L; AUDIA, J. E et al.The Journal of pharmacology and experimental therapeutics. 1993, Vol 265, Num 3, pp 1272-1279, issn 0022-3565Article

Characteristics of ³H-ketanserin binding to human platelet membraneOHSUKA, N; OKANO, T; KANNO, T et al.Neurosciences (Okayama). 1992, Vol 18, Num 2, pp 105-112, issn 0388-7448Article

Increase in serotonin₂ receptor density in rat cerebral cortex slices by stimulation of beta-adrenergic receptorsSCOTT, J. A; CREWS, F. T.Biochemical pharmacology. 1985, Vol 34, Num 9, pp 1585-1588, issn 0006-2952Article

Behavioural and biochemical evidence that glucocorticoids are not involved in DOI-elicited 5-HT₂ receptor down-regulationCHAOULOFF, F; BAUDRIE, V; COUPRY, I et al.European journal of pharmacology. 1993, Vol 249, Num 1, pp 117-120, issn 0014-2999Article

Target size analysis of serotonin 5-HT₁ and 5-HT₂ receptors in bovine brain membranesNISHINO, N; TANAKA, C.Life sciences (1973). 1985, Vol 37, Num 12, pp 1167-1174, issn 0024-3205Article

Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the ratRUPNIAK, N. M. J; HALL, M. D; MANN, S et al.Biochemical pharmacology. 1985, Vol 34, Num 15, pp 2755-2763, issn 0006-2952Article

³H-ketanserin and ³H-imipramide binding to platelets from humansOKANO, T; TOSHIMA, T; OHSUKA, Y et al.Neurosciences (Okayama). 1992, Vol 18, Num AVR, pp P37-P40, issn 0388-7448, SUPConference Paper

Ketanserin (S₂-receptor blocking agent), platelet activity and chronic alcoholismSANTINI, P; CECCANTI, M; DE LORENZO, A et al.International journal of clinical pharmacology research. 1986, Vol 6, Num 1, pp 73-76, issn 0251-1649Article

Characterization of the 5-HT_1B recognition site in rat brain: binding studies with (-)[¹²⁵I]iodocyanopindololHOYER, D; ENGEL, G; KALKMAN, H. O et al.European journal of pharmacology. 1985, Vol 118, Num 1-2, pp 1-12, issn 0014-2999Article

Serotonin 5-HT2 receptor binding on blood platelets. A peripheral marker for depression?BIEGON, A; WEIZMAN, A; KARP, L et al.Life sciences (1973). 1987, Vol 41, Num 22, pp 2485-2492, issn 0024-3205Article

Photoaffinity labelling of serotonin-S₂ receptors with 7-azidoketanserinWOUTERS, W; VAN DUN, J; LEYSEN, J. E et al.European journal of pharmacology. 1985, Vol 107, Num 3, pp 399-400, issn 0014-2999Article

Differential photoaffinity labelling of serotonin-S₂ receptors and histamine-H₁ receptors using 7-azidoketanserinWOUTERS, W; VAN DUN, J; LEYSEN, J. E et al.FEBS letters. 1985, Vol 182, Num 2, pp 291-296, issn 0014-5793Article

Verapamil, an antagonist at 5-hydroxytryptamine receptors of human blood plateletsAFFOLTER, H; BURKARD, W. P; PLETSCHER, A et al.European journal of pharmacology. 1985, Vol 108, Num 2, pp 157-162, issn 0014-2999Article